Loading
Loading
The most overhyped supplement in the hair category. Biotin deficiency is extremely rare in healthy adults, and supplementation in non-deficient individuals has zero clinical evidence for hair growth. The $4 billion biotin market is built almost entirely on social media hype, not science.
Biotin receives the largest hype penalty in our database (15 points) because the gap between marketing claims and evidence is enormous. The $4B biotin market is fueled by influencer marketing, Amazon reviews, and 'hair, skin, nails' branding -- not clinical trials. The product is cheap and relatively safe, but spending money on something with no evidence of benefit in non-deficient people is still a waste. The lab test interference issue is a genuine safety concern at high doses.
Biotin (vitamin B7) is essential for hair, skin, and nail health -- when deficient. However, biotin deficiency is exceedingly rare in healthy adults eating a normal diet. There are zero published randomized controlled trials demonstrating that biotin supplementation improves hair growth in non-deficient individuals. The few case reports showing benefit involved patients with documented biotin deficiency or rare genetic disorders. The 10,000mcg dose is 33,333% of the Daily Value -- massive overdosing with no evidence of benefit. High-dose biotin can interfere with lab tests including troponin (heart attack marker) and thyroid panels.
| Ingredient | Dose | Verdict |
|---|---|---|
| Biotin (D-Biotin) | 10,000mcg | Unnecessary |
Zero RCTs showing benefit for hair growth in non-deficient adults. 10,000mcg is 33,333% of Daily Value with no dose-response evidence. Can interfere with lab tests (troponin, thyroid panels) -- inform your doctor. Biotin deficiency is extremely rare. The entire market is built on hype, not evidence. If your hair is thinning, see a dermatologist.
Biorank may earn a commission from qualifying purchases. This does not influence our scores or rankings.
Better-rated options in Hair Growth
Popular picks in Hair Growth